An experimental gene-editing therapy that aims to lower bad cholesterol for the long-term after a single infusion is off to a ...

Patients in London have received a pioneering new gene editing therapy that lowers "bad" cholesterol after a single infusion, ...

For the roughly 30 million American adults who have been told their cholesterol is too high but cannot stomach a statin, the ...

Regular follow-up calls from a pharmacist can help people lower their "bad" (LDL) cholesterol by reminding them to take their ...

There is broad consensus that the overall body of evidence shows lowering LDL (low-density lipoprotein) cholesterol provides both statistically significant and clinically meaningful benefits in ...

The cholesterol medication alirocumab, a PCSK9 inhibitor, combined with a statin appeared to reduce LDL cholesterol levels by more than 50% among patients after a heart transplant, according to a late ...

Recent research suggests that the majority of side effects commonly linked to statins are not, in fact, caused by the medication itself. A comprehensive study, published in The Lancet, examined data ...

The cholesterol-lowering medication alirocumab, a PCSK9 inhibitor, along with a statin, lowered LDL cholesterol levels more than 50% in patients after a heart transplant, compared to those taking a ...

NEW ORLEANS — Lowering the level of low-density lipoprotein (LDL) cholesterol to below 40 mg/dL — well beneath current poststroke guideline targets — reduced major cardiovascular events without ...

Experts share the common evening habits that may be working against your cholesterol goals, plus what to do instead.